AC Immune
ACIU
48 hedge funds and large institutions have $163M invested in AC Immune in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
75% more capital invested
Capital invested by funds: $93M → $163M (+$69.7M)
33% more funds holding
Funds holding: 36 → 48 (+12)
0.45% more ownership
Funds ownership: 27.81% → 28.26% (+0.45%)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.16M |
| 2 |
Renaissance Technologies
New York
|
+$715K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$648K |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$544K |
| 5 |
BI
BVF Inc
San Francisco,
California
|
+$297K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
ALPS Advisors
Denver,
Colorado
|
-$667K |
| 2 |
Millennium Management
New York
|
-$485K |
| 3 |
PC
PA Capital
Richmond,
Virginia
|
-$377K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$317K |
| 5 |
BlackRock
New York
|
-$261K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AP
51
Appleton Partners
Boston,
Massachusetts
| – | -$57K | -11,525 | Closed |
|
|
QT
52
Quantamental Technologies
White Plains,
New York
| – | -$9K | -1,743 | Closed |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -491 | Closed |
|
ACIU Hedge Fund Activity: Q4 2019 in Review
48 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2019, worth a combined $163M — up 75% from $93M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ACIU positions and 5 closed out — a net gain of 12 holders — while 11 added to existing stakes and 15 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $1.16M. The largest seller was ALPS Advisors, exiting entirely with an estimated $667K sold.
- 48 institutional investors held AC Immune (ACIU) as of Q4 2019, up from 36 in Q3 2019.
- Funds reported $163M of AC Immune stock for Q4 2019, up 75% quarter-over-quarter.
- 17 funds opened new AC Immune positions in Q4 2019 and 5 closed out, a net change of +12 holders.
- The largest AC Immune buyer in Q4 2019 was Acadian Asset Management, an estimated $1.16M added.
- The largest AC Immune seller in Q4 2019 was ALPS Advisors, an estimated $667K sold.
Based on aggregated 13F filings for Q4 2019.